| Genetic Name | Therapeutic Category | Status | NCE-1 Date |
| Darolutamide | Oncology | Developed |
|
| Everolimus | Oncology | Developed | - |
| Elacestrant | Oncology | R&D | 27-Jan-27 |
| Exemestane | Oncology | R&D | - |
| Osimertinib | Oncology | Pilot | - |
| Resmetirom | NASH | Pilot | - |
| Umeclidinium Bromide | COPD | R&D | - |
| Vilanterol | COPD | R&D | - |
| Rimegepant | Migraine headache | Pilot | 27-Feb-24 |
| Tirzepatide | Type II diabetic | R&D | 13-May-26 |
| Vosoritide | Achondroplasia | R&D | 19-Nov-25 |
| Inclisiran | Hyperlipidemia (siRNA) | Pilot | 22-Dec-25 |
| Vutrisiran | ATTR (siRNA) | R&D | 13-Jun-26 |
| Risdiplam | Spinal Muscular Atrophy (SMA) | Developed | 7-Aug-24 |
| Filgotinib | Rheumatoid arthritis (JAK1) | Developed | - |
| Upadacitinib | Rheumatoid arthritis (JAK1) | Pilot |
|
| Estetrol | Estrogen | R&D | 15-Apr-25 |
| Progesterone | Progestogen | Pilot | - |
| Methylprednisolone | Anti-inflammatory | R&D | - |
| Zuranolone | MDD&PPD | R&D | 4-Aug-27 |